Clyzo Blog Details

Excipient Sourcing & Suppliers

Pharmaceutical Excipient Manufacturers in India

03-07-2026

Industry Overview, Challenges, and the Future of Domestic Sourcing

India is a global pharmacy. The country supplies over 200 nations with medicines, exports more than 50 percent of its pharmaceutical output, and manufactures a significant share of the world's generic drugs and vaccines. Yet there is a structural gap that is rarely talked about publicly: India imports a large portion of the specialty excipients it uses to make those drugs.

This piece is for pharmaceutical professionals, procurement leads, and industry observers who want to understand the pharmaceutical excipient manufacturing landscape in India, including who is producing what, what gaps exist, and where the industry is heading.

Understanding the Role of Pharma Excipients in Drug Manufacturing

Pharmaceutical excipients are the non-active ingredients in a drug product. They serve dozens of functional purposes depending on the dosage form and route of administration. In a tablet, excipients act as binders, disintegrants, fillers, lubricants, and coatings. In an injectable, they function as buffers, stabilizers, tonicity agents, surfactants, and preservatives.

Excipients are not inert. They directly affect the drug's stability, bioavailability, safety profile, and patient experience. Choosing the wrong excipient, or using a correctly chosen excipient of poor quality, can make a drug ineffective, unstable, or unsafe.

That is why the pharma excipient market in India is attracting more attention from manufacturers, regulators, and investors than ever before.

The Scale of India's Pharma Excipient Market

The pharmaceutical excipient market in India was valued at approximately USD 1.8 to 2.1 billion in 2025. It is projected to grow at a compound annual growth rate of 7.5 to 9 percent through 2031, driven by the expansion of injectable and biologic drug manufacturing, growth in vaccine production, and India's continuing push to penetrate regulated export markets.

India received 248 shipments of pharmaceutical excipients from international sources between October 2023 and September 2024, representing a 25 percent year-on-year increase. This tells you something important: Indian demand for excipients is growing faster than domestic supply of specialty grades.

What Pharmaceutical Excipient Manufacturers in India Currently Produce

India does have domestic excipient manufacturing capacity, but it is concentrated in specific categories:

Broadly Available Domestic Products

Indian manufacturers are well established in the production of basic and bulk excipients:

Microcrystalline cellulose (MCC) for oral solid dosage forms
Lactose monohydrate for dry powder inhalation and oral formulations
Starch and modified starches as binders and disintegrants
Talc, magnesium stearate, and silicon dioxide as glidants and lubricants
Povidone (PVP) grades for binders
Basic sugars including sucrose and dextrose for conventional oral and some parenteral use
Sodium chloride for tonicity adjustment
Calcium phosphate, mannitol, and sorbitol for granulation and oral use

Areas with Limited Domestic Manufacturing

This is where the supply gap becomes visible. For several categories of specialty and injectable-grade excipients, India depends heavily on imports:

Pharmaceutical-grade polysorbates (20 and 80) at parenteral specifications
Low-endotoxin amino acids (histidine, arginine, methionine, glycine) for biologic injectables
Pharmaceutical-grade gelatin and collagen peptide alternatives for biologics and vaccines
Cyclodextrins (HP-beta-cyclodextrin, sulfobutylether-beta-cyclodextrin) for solubilization
PEG grades for parenteral use
Adjuvants including aluminum hydroxide gels meeting injectable specifications
Lipid excipients for lipid nanoparticle formulations used in mRNA vaccines and gene therapies
Co-processed excipients designed for complex generics
Specialty cellulose derivatives like HPMC-AS for amorphous solid dispersions

Who Are the Key Pharmaceutical Excipient Manufacturers and Suppliers in India?

Domestic Manufacturers

Several Indian companies manufacture bulk excipients domestically:

Anil Bioplus produces sorbitol, mannitol, and related polyols for pharmaceutical use
Sigachi Industries is a significant manufacturer of microcrystalline cellulose (Avicel alternatives)
S D Fine Chemicals (Sdfchem) produces a range of laboratory and pharmaceutical chemicals
Merck India (a separate entity from the US Merck) produces some excipient categories

Global Suppliers with India Operations

International excipient majors have established a presence in India:

BASF supplies multiple excipient categories including PVP, polysorbates, and specialty polymers
Dow supplies cellulosics and other functional excipients
Roquette supplies mannitol, sorbitol, starches, and specialty excipients
Clariant launched several made-in-India excipients at CPHI India 2024 including ultra-pure co-solvents and colorless polysorbate grades for parenteral use
Ashland supplies specialty cellulose derivatives including Klucel and Benecel grades

Importers and Distributors

A large segment of the specialty excipient supply chain in India is served by importers who source from global manufacturers and supply to Indian pharma companies. This channel has historically been fragmented, with documentation quality varying widely.

Clyzo: India's First E-Commerce Platform for Pharma Excipient Procurement

In 2022, Pharmonix Biologicals launched Clyzo (clyzo.com) at CPHI India, positioning it as India's first e-commerce portal for pharmaceutical excipient procurement. The platform was developed specifically to address the fragmented and documentation-poor sourcing ecosystem that Indian pharmaceutical manufacturers faced.

Clyzo provides access to over 1800 rare and specialty excipients across more than 40 categories, including parenteral-grade amino acids, vaccine excipients, plasma raw materials, and regulatory-compliant excipients meeting USP, EP, BP, and JP monograph standards.

Key features of the platform include:

Instant quote generation without the need for multiple phone calls or emails
Access to batch-specific CoAs and regulatory documentation
Monograph comparison tools for USP, EP, and JP specifications
Online ordering and tracking
Volume pricing for large production quantities with just-in-time delivery options
A RegPro service providing regulatory documentation support for pharma approvals

The platform is particularly valuable for mid-size Indian pharmaceutical companies that lack dedicated procurement teams to manage complex specialty excipient sourcing from multiple international suppliers.

Why India Needs Stronger Domestic Excipient Manufacturing

The COVID-19 pandemic exposed the vulnerability of global supply chains, including pharmaceutical raw material supply. For India, which positions itself as a global medicine supplier, depending on Europe and Japan for key excipients is a strategic risk.

There are at least five compelling reasons to develop domestic pharmaceutical excipient manufacturing in India:

Supply chain resilience: Domestic sourcing reduces dependence on international shipping timelines, currency risk, and geopolitical disruptions.

Cost competitiveness: As Indian pharma companies compete on price in generic markets, the cost of imported specialty excipients is a real pressure on margins.

Regulatory alignment: Companies that source from domestic manufacturers with strong GMP systems can audit sites more easily and maintain closer relationships.

Speed to market: Domestic sourcing means faster procurement cycles, lower minimum order quantities, and more flexible delivery scheduling.

National pharmaceutical security: India's ability to respond rapidly to health emergencies depends in part on domestic availability of critical raw materials, including excipients.

Government and Regulatory Initiatives Supporting Excipient Manufacturing in India

The Production Linked Incentive (PLI) scheme for pharmaceuticals in India has primarily targeted API manufacturing, but there is growing recognition that excipient manufacturing needs similar support.

The revised Schedule M GMP regulations are pushing Indian pharmaceutical manufacturers to qualify their excipient supply chains more rigorously, which in turn is creating demand signals for better-quality domestic excipient suppliers.

India's National Pharmaceutical Policy discussions have included references to reducing raw material import dependency, which encompasses excipients alongside APIs.

What Pharmaceutical Professionals Should Know About Sourcing Excipients in India

If you are sourcing pharma excipients in India today, here is practical guidance:

For basic excipients in oral solid dosage forms, domestic sourcing from established manufacturers is well-supported and cost-effective.

For injectable-grade and specialty excipients, verified imports remain the primary channel. Working with a platform like Clyzo (clyzo.com) that consolidates supply, documentation, and regulatory support significantly reduces the procurement burden.

For rare or novel excipients (cyclodextrins, lipids, specialty amino acids), international suppliers are currently the primary source. Clyzo's rare excipient finder feature is specifically designed for this category.

For regulatory submissions to USFDA, EMA, or WHO PQ, ensure that every excipient in your product has a current, batch-specific CoA, a GMP certificate from the supplier's manufacturing site, and documented endotoxin testing for parenteral grades.

Frequently Asked Questions

What is the largest category of pharmaceutical excipients produced in India?

India has the strongest domestic production in oral solid dosage excipients including microcrystalline cellulose, lactose, mannitol (for oral use), starches, and basic lubricants and glidants.

Are specialty injectable excipients manufactured in India?

Currently, most specialty injectable-grade excipients including low-endotoxin amino acids, pharmaceutical-grade polysorbates, and lipid nanoparticle components are imported. Domestic production of these categories is limited but growing.

How can a pharma company qualify a domestic excipient supplier in India?

Supplier qualification involves a site audit or questionnaire assessment, review of the supplier's GMP certification and quality system, testing of product samples against pharmacopoeial specifications, and a formal vendor approval process documented in the company's quality management system.

What is India's first e-commerce platform for pharmaceutical excipient procurement?

Clyzo (clyzo.com), launched by Pharmonix Biologicals in 2022, is India's first dedicated e-commerce portal for pharmaceutical excipient procurement, offering access to specialty and rare excipients with full regulatory documentation.

Published on clyzo.com | Supporting pharmaceutical excipient manufacturers and buyers across India

Vaccine Excipients Oral Topical Biopharma

Ethanol 96% v/v for pharmaceutical excipients (Ph.... ... Ethanol 96% v/v for pharmaceutical excipients (Ph.Eur., BP, USP IPEC Grade) | Clyzo Read more

14-08-2026